Collectively, these studies demonstrate the diverse regulatory functions of MEG3 in prostate cancer, providing potential insights into its impact on cancer progression and facilitating the identification of novel therapeutic targets for this disease. This evidence concerns the gene MEG3 and Familial prostate cancer.